Claim Details
View detailed information about this claim and its related sources.
Claim Information
Complete details about this extracted claim.
- Claim Text
-
That is the result of a 2003 law, in effect written by the industry, preventing the federal government from seeking bids for the manufacture of drugs and medical devices – a process used in other areas, such as defence spending.
- Simplified Text
-
A 2003 law prevents the federal government from seeking bids for drug manufacture
- Confidence Score
- 0.900
- Claim Maker
- Chris McGreal
- Context Type
- News Article
- Context Details
-
{ "law": "2003 law", "impact": "Prevents federal bidding for drug manufacture", "industry": "Pharmaceutical" } - Subject Tags
- UUID
- 9fdb30b8-de40-4509-b1f9-5c7ecfd62bd5
- Vector Index
- ✗ No vector
- Created
- September 12, 2025 at 12:40 AM (1 day ago)
- Last Updated
- September 12, 2025 at 12:40 AM (1 day ago)
Original Sources for this Claim (1)
All source submissions that originally contained this claim.
23
claims
🔥
1 day ago
https://www.theguardian.com/us-news/2017/oct/19/big-pharma-money-lobbying-us-opioid-crisis
Pharmaceutical industry lobbying and campaign contributions heavily influence US politics, hindering efforts to curb the opioid crisis. This influence is seen in legislation, impacting drug pricing and the DEA's ability to regulate opioid distribution.
Similar Claims (0)
Other claims identified as semantically similar to this one.
No similar claims found
This claim appears to be unique in the system.